354 related articles for article (PubMed ID: 25753668)
41. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).
Riley JL; Westerheide SD; Price JA; Brown JA; Boss JM
Immunity; 1995 May; 2(5):533-43. PubMed ID: 7749984
[TBL] [Abstract][Full Text] [Related]
42. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
[TBL] [Abstract][Full Text] [Related]
43.
Sengupta S; Naz S; Das I; Ahad A; Padhi A; Naik SK; Ganguli G; Pattanaik KP; Raghav SK; Nandicoori VK; Sonawane A
J Biol Chem; 2017 Apr; 292(17):6855-6868. PubMed ID: 28209712
[No Abstract] [Full Text] [Related]
44. Protein kinase C delta is essential to maintain CIITA gene expression in B cells.
Kwon MJ; Soh JW; Chang CH
J Immunol; 2006 Jul; 177(2):950-6. PubMed ID: 16818750
[TBL] [Abstract][Full Text] [Related]
45. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
46. Chromatin remodeling and extragenic transcription at the MHC class II locus control region.
Masternak K; Peyraud N; Krawczyk M; Barras E; Reith W
Nat Immunol; 2003 Feb; 4(2):132-7. PubMed ID: 12524537
[TBL] [Abstract][Full Text] [Related]
47. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter.
Adamski J; Ma Z; Nozell S; Benveniste EN
Mol Endocrinol; 2004 Aug; 18(8):1963-74. PubMed ID: 15143155
[TBL] [Abstract][Full Text] [Related]
48. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
Tooze RM; Stephenson S; Doody GM
J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
[TBL] [Abstract][Full Text] [Related]
49. Modulation of gene expression by the MHC class II transactivator.
Nagarajan UM; Bushey A; Boss JM
J Immunol; 2002 Nov; 169(9):5078-88. PubMed ID: 12391224
[TBL] [Abstract][Full Text] [Related]
50. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.
Huang XP; Ludke A; Dhingra S; Guo J; Sun Z; Zhang L; Weisel RD; Li RK
FASEB J; 2016 Sep; 30(9):3069-82. PubMed ID: 27221978
[TBL] [Abstract][Full Text] [Related]
51. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
Chang CH; Guerder S; Hong SC; van Ewijk W; Flavell RA
Immunity; 1996 Feb; 4(2):167-78. PubMed ID: 8624807
[TBL] [Abstract][Full Text] [Related]
52. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells.
Piskurich JF; Lin KI; Lin Y; Wang Y; Ting JP; Calame K
Nat Immunol; 2000 Dec; 1(6):526-32. PubMed ID: 11101876
[TBL] [Abstract][Full Text] [Related]
53. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
Bhat KP; Truax AD; Brooks JK; Greer SF
Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
Bhat KP; Truax AD; Greer SF
J Biol Chem; 2010 Aug; 285(34):25893-903. PubMed ID: 20538595
[TBL] [Abstract][Full Text] [Related]
55. Early epigenetic events regulate the adaptive immune response gene CIITA.
Mehta NT; Truax AD; Boyd NH; Greer SF
Epigenetics; 2011 Apr; 6(4):516-25. PubMed ID: 21266852
[TBL] [Abstract][Full Text] [Related]
56. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
57. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
[TBL] [Abstract][Full Text] [Related]
58. CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments.
Zinzow-Kramer WM; Long AB; Youngblood BA; Rosenthal KM; Butler R; Mohammed AU; Skountzou I; Ahmed R; Evavold BD; Boss JM
Genes Immun; 2012 Jun; 13(4):299-310. PubMed ID: 22218223
[TBL] [Abstract][Full Text] [Related]
59. CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.
Majumder P; Boss JM
Mol Cell Biol; 2010 Sep; 30(17):4211-23. PubMed ID: 20584980
[TBL] [Abstract][Full Text] [Related]
60. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
Nakano N; Nishiyama C; Yagita H; Koyanagi A; Ogawa H; Okumura K
J Biol Chem; 2011 Apr; 286(14):12042-8. PubMed ID: 21321116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
